Skip to main content
OpenTrials
Completed

NCT Number: NCT01051375

Examining the Effectiveness of a Wait List Intervention for the Management of Adolescent Eating Disorders

The current application targets patient education and enablement, implementation of best practices, continuity of care, and an improvement model to improve efficiencies by investigating whether a brief targeted intervention prior to the first formal ED assessment is efficacious in altering outcome and treatment course.

Completed

Looking for future studies?

Notify Me

Key information

Age range

10 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Hospital of Eastern Ontario

Ottawa, Ontario, K1H 8L1, Canada

About this study

The Eating Disorder Program at the Children's Hospital of Eastern Ontario (CHEO) offers a continuum of treatment options to child and adolescent patients with eating disorders (EDs). Although our own funding has increased in recent years, so too have the number of referrals, which has resulted in lengthy wait times for therapeutic assessments by our team. The current application targets patient education and enablement, implementation of best practices, continuity of care, and an improvement model to improve efficiencies by investigating whether a brief targeted intervention prior to the first formal ED assessment is efficacious in altering outcome and treatment course. It is well known that early recognition and implementation of treatment as soon as possible after the onset of symptoms is protective in eating disorders and leads to better success rates and recovery (APA Treatment Guidelines for EDs). It is hoped that the outcome of this study will influence the way in which centers look to address the ongoing issue of lengthy wait times in hopes of offering cost-effective interventions that ultimately improve patient outcomes. By offering an added level of support to families whose referral has been initiated, we hope to ease the burden of primary care providers and increase their satisfaction as it relates to patient safety concerns and complex case management.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • medical stability at time of referral
  • completed referral to the Eating Disorders Program

Exclusion criteria

  • patients deemed medically unstable are triaged urgently and not eligible for study inclusion

Treatment and study plan

Psychoeducational Workshop and telephone support

Behavioral

The intervention involves completion of a single workshop (delivered by a psychiatrist and adolescent health physician), provision of psycho educational materials, and regular telephone support with a specially trained nurse-coordinator to parents of youth on our waiting list.

Primary outcomes

  1. Investigate whether a wait list intervention for patients and families who are on a wait list, improves patient presentation at the time of formal assessment, as well as 6-months post-assessment

    Time frame: 18 months

Secondary outcomes

  1. Evaluate the impact that a wait list intervention group workshop has on caregiver knowledge, stress, and self-efficacy pertaining to eating disorders and their treatment

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

University of Ottawa

Other

Registry information

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Jan 18, 2010
Registry last updated
May 12, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.